Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins

被引:140
作者
Kimura, H
Takeda, M
Narikawa, S
Enomoto, A
Ichida, K
Endou, H
机构
[1] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 181, Japan
[2] Jikeikai Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan
关键词
D O I
10.1124/jpet.301.1.293
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Prostaglandin E-2 (PGE(2)) and prostaglandin F-2alpha (PGF(2alpha)) have been used for the induction of labor and the termination of pregnancy. Renal excretion is shown to be an important pathway for the elimination of PGE(2) and PGF(2alpha). The purpose of this study was to elucidate the molecular mechanism of renal PGE2 and PGF(2alpha) transport using cells stably expressing human organic anion transporter (hOAT) 1, hOAT2, hOAT3, and hOAT4, and human organic cation transporter (hOCT) 1 and hOCT2. A time- and dose-dependent increase in PGE(2) and PGF(2alpha) uptake was observed in cells expressing hOAT1, hOAT2, hOAT3, hOAT4, hOCT1, and hOCT2. The K-m values of PGE(2) uptake by hOAT1, hOAT2, hOAT3, hOAT4, hOCT1, and hOCT2 were 970, 713, 345, 154, 657, and 28.9 nM, respectively, whereas those of PGF(2alpha) uptake by hOAT1, hOAT3, hOAT4, hOCT1, and hOCT2 were 575, 1092, 692, 477, and 334 nM, respectively. PGE(2) and PGF(2alpha) significantly inhibited organic anion uptake by hOATs and organic cation uptake by hOCTs. In conclusion, considering the localization of these transporters, the results suggest that PGE(2) and PGF(2alpha) transport in the basolateral membrane of the proximal tubule is mediated by multiple pathways including hOAT1, hOAT2, hOAT3, and hOCT2, whereas that in the apical side is mediated by hOAT4.
引用
收藏
页码:293 / 298
页数:6
相关论文
共 39 条
[1]  
ALTMAN DF, 2000, BASIC CLIN PHARM, P1064
[2]  
BABU E, 2002, IN PRESS BIOCH BIOPH
[3]  
BREYER MD, 1996, KIDNEY, P754
[4]   Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine [J].
Busch, AE ;
Karbach, U ;
Miska, D ;
Gorboulev, V ;
Akhoundova, A ;
Volk, C ;
Arndt, P ;
Ulzheimer, JC ;
Sonders, MS ;
Baumann, C ;
Waldegger, S ;
Lang, F ;
Koepsell, H .
MOLECULAR PHARMACOLOGY, 1998, 54 (02) :342-352
[5]   Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta [J].
Cha, SH ;
Sekine, T ;
Kusuhara, H ;
Yu, E ;
Kim, JY ;
Kim, DK ;
Sugiyama, Y ;
Kanai, Y ;
Endou, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (06) :4507-4512
[6]   Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney [J].
Cha, SH ;
Sekine, T ;
Fukushima, J ;
Kanai, Y ;
Kobayashi, Y ;
Goya, T ;
Endou, H .
MOLECULAR PHARMACOLOGY, 2001, 59 (05) :1277-1286
[7]  
FOEGH ML, 2001, BASIC CLIN PHARM, P311
[8]   Cloning and characterization of two human polyspecific organic cation transporters [J].
Gorboulev, V ;
Ulzheimer, JC ;
Akhoundova, A ;
UlzheimerTeuber, I ;
Karbach, U ;
Quester, S ;
Baumann, C ;
Lang, F ;
Busch, AE ;
Koepsell, H .
DNA AND CELL BIOLOGY, 1997, 16 (07) :871-881
[9]   DRUG EXCRETION MEDIATED BY A NEW PROTOTYPE OF POLYSPECIFIC TRANSPORTER [J].
GRUNDEMANN, D ;
GORBOULEV, V ;
GAMBARYAN, S ;
VEYHL, M ;
KOEPSELL, H .
NATURE, 1994, 372 (6506) :549-552
[10]   Cisplatin-induced toxicity in immortalized renal cell lines established from transgenic mice harboring temperature sensitive SV40 large T-antigen gene [J].
Hosoyamada, M ;
Obinata, M ;
Suzuki, M ;
Endou, H .
ARCHIVES OF TOXICOLOGY, 1996, 70 (05) :284-292